The HER2-TTC/PARPi combination was evaluated on colorectal adenocarcinoma HER-2 positive cell line DLD-1 parental and DLD-1 BRCA2 −/− with an inactivation of BRCA2, a gene involved in DNA DSBs repair. This evidence concerns the gene BRCA2 and colorectal adenocarcinoma.